BPC-157 Dosage and Protocol: An Evidence-Based Guide BPC-157 is a 15-amino-acid peptide derived from human gastric juice, with documented stability in gastric acid that distinguishes it from almost every other therapeutic peptide
Observational data from practitioner-supervised use, even informal, contribute to the pre-clinical-to-clinical evidence bridge that BPC-157 currently lacks
Arcan P, Bozkurt O, Cavusoglu D, Gencpnar P, Haspolat S, Duman O, Olgac Dundar N
Then, in 2015, Lee and colleagues identified a previously overlooked open reading frame within the 12S ribosomal RNA gene of mtDNA and found that it encodes a functional peptide, MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) [1]
Most practitioners recommend discontinuing treatment while pregnant or nursing
The NDC follows a standard three-segment format assigned by the FDA at the time of product registration